Extent, patterns, and burden of uncontrolled disease in severe or difficult‐to‐treat asthma

SD Sullivan, L Rasouliyan, PA Russo, T Kamath… - Allergy, 2007 - Wiley Online Library
Background: Characterization of uncontrolled asthma burden in a natural treatment setting
can influence treatment recommendations and clinical practice. The objective was to …

Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study

JH Lee, T Haselkorn, L Borish, L Rasouliyan… - Chest, 2007 - Elsevier
Background The Epidemiology and Natural History of Asthma: Outcomes and Treatment
Regimens study is among the largest to assess persistent airflow limitation and the first to …

Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample

…, GS Sawicki, A McMullen, L Rasouliyan… - Quality of Life …, 2012 - Springer
Purpose The psychometric properties of a health-related quality of life (HRQOL) instrument,
the Cystic Fibrosis Questionnaire-Revised (CFQ-R), were evaluated in a national sample of …

[HTML][HTML] Adding 3D automated breast ultrasound to mammography screening in women with heterogeneously and extremely dense breasts: Report from a hospital …

B Wilczek, HE Wilczek, L Rasouliyan… - European journal of …, 2016 - Elsevier
Purpose The aim of this study was to evaluate the impact of the 3D automated breast ultrasound
(3D ABUS) when added to full field digital screening mammography (FFDSM), on breast …

Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States

AL Quittner, MS Schechter, L Rasouliyan, T Haselkorn… - Chest, 2010 - Elsevier
Background Patient-reported outcomes are increasingly used in clinical trials to assess the
natural history of chronic diseases and the efficacy of new treatments. Understanding the …

Longitudinal assessment of health‐related quality of life in an observational cohort of patients with cystic fibrosis

GS Sawicki, L Rasouliyan, AH McMullen… - Pediatric …, 2011 - Wiley Online Library
Background Patient‐reported outcomes (PROs) are increasingly used to evaluate the
efficacy of new treatments and the progression of chronic diseases. The Cystic Fibrosis …

[HTML][HTML] Risk factors for rate of decline in FEV1 in adults with cystic fibrosis

…, DJ Pasta, A Yegin, L Rasouliyan… - Journal of Cystic …, 2012 - Elsevier
BACKGROUND: Previously we assessed risk factors for FEV 1 decline in children and
adolescents using the Epidemiologic Study of Cystic Fibrosis (J Pediatr 2007;151:134–139); the …

Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis

JS Wagener, L Rasouliyan… - Pediatric …, 2013 - Wiley Online Library
Rationale Patients with cystic fibrosis (CF) experience frequent pulmonary exacerbations (PExs).
Clinicians manage these episodes of worsening signs and symptoms in a variety of …

Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global …

…, H Hiramatsu, HE Stefanski, L Rasouliyan, L Yi… - The Lancet …, 2019 - thelancet.com
Background The ELIANA trial showed that 61 (81%) of 75 paediatric and young adult
patients with relapsed or refractory B-cell acute lymphoblastic leukaemia achieved overall …

Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma

AT Luskin, BE Chipps, L Rasouliyan, DP Miller… - The Journal of Allergy …, 2014 - Elsevier
L. Rasouliyan has received consulting fees from ICON Clinical Research. DP Miller has
received funding from Genentech through his employer, ICON, for statistical support of the …